Literature DB >> 10550329

Motility induced by human immunodeficiency virus-1 Tat on Kaposi's sarcoma cells requires platelet-activating factor synthesis.

L Biancone1, V Cantaluppi, M Boccellino, B Bussolati, L Del Sorbo, P G Conaldi, A Albini, A Toniolo, G Camussi.   

Abstract

In the present study, we evaluated whether motility of Kaposi's sarcoma (KS) spindle cells induced by HIV-1 Tat protein is dependent on the synthesis of platelet-activating factor (PAF). The results obtained indicate that Tat induced a dose-dependent synthesis of PAF from KS cells at a concentration as low as 0.1 ng/ml. PAF production started rapidly after Tat stimulation, peaking at 30 minutes and declining thereafter. Tat-induced cell migration was also a rapid event starting at 30 minutes. The motility was abrogated by addition of a panel of chemically unrelated PAF receptor antagonists (WEB 2170, CV 3988, CV 6209, and BN 52021), suggesting that the synthesized PAF mediates the motogenic effect of Tat. This effect was also present on cells plated on a type-I collagen-, fibronectin-, or basement membrane extract-coated surface. Expression of PAF receptor-specific mRNA was detected in KS cells. In addition, examination of the cytoskeletal organization showed that Tat-mediated KS cell redistribution of actin filaments and shape change was also inhibited by a PAF receptor antagonist. Moreover, PAF receptor blockade prevented the up-regulation of beta1 integrin and the down-regulation of alphavbeta3 observed after stimulation of KS cells with Tat. In conclusion, the results of the present study indicate that Tat-induced PAF synthesis plays a critical role in triggering the events involved in motility of KS cells.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10550329      PMCID: PMC1866979          DOI: 10.1016/S0002-9440(10)65488-0

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  28 in total

1.  Platelet-activating factor directly stimulates in vitro migration of endothelial cells and promotes in vivo angiogenesis by a heparin-dependent mechanism.

Authors:  G Camussi; G Montrucchio; E Lupia; A De Martino; L Perona; M Arese; A Vercellone; A Toniolo; F Bussolino
Journal:  J Immunol       Date:  1995-06-15       Impact factor: 5.422

2.  HIV-1 Tat protein mimicry of chemokines.

Authors:  A Albini; S Ferrini; R Benelli; S Sforzini; D Giunciuglio; M G Aluigi; A E Proudfoot; S Alouani; T N Wells; G Mariani; R L Rabin; J M Farber; D M Noonan
Journal:  Proc Natl Acad Sci U S A       Date:  1998-10-27       Impact factor: 11.205

3.  Integrin-ligand binding properties govern cell migration speed through cell-substratum adhesiveness.

Authors:  S P Palecek; J C Loftus; M H Ginsberg; D A Lauffenburger; A F Horwitz
Journal:  Nature       Date:  1997-02-06       Impact factor: 49.962

4.  Angiogenesis induced in vivo by hepatocyte growth factor is mediated by platelet-activating factor synthesis from macrophages.

Authors:  G Camussi; G Montrucchio; E Lupia; R Soldi; P M Comoglio; F Bussolino
Journal:  J Immunol       Date:  1997-02-01       Impact factor: 5.422

5.  The angiogenesis induced by HIV-1 tat protein is mediated by the Flk-1/KDR receptor on vascular endothelial cells.

Authors:  A Albini; R Soldi; D Giunciuglio; E Giraudo; R Benelli; L Primo; D Noonan; M Salio; G Camussi; W Rockl; F Bussolino
Journal:  Nat Med       Date:  1996-12       Impact factor: 53.440

6.  Monoclonal origin of multicentric Kaposi's sarcoma lesions.

Authors:  C S Rabkin; S Janz; A Lash; A E Coleman; E Musaba; L Liotta; R J Biggar; Z Zhuang
Journal:  N Engl J Med       Date:  1997-04-03       Impact factor: 91.245

Review 7.  AIDS-associated Kaposi's sarcoma pathogenesis, clinical features, and treatment.

Authors:  R Masood; J Cai; R Law; P Gill
Journal:  Curr Opin Oncol       Date:  1993-09       Impact factor: 3.645

8.  Miller-Dieker lissencephaly gene encodes a subunit of brain platelet-activating factor acetylhydrolase [corrected].

Authors:  M Hattori; H Adachi; M Tsujimoto; H Arai; K Inoue
Journal:  Nature       Date:  1994-07-21       Impact factor: 49.962

9.  Platelet activating factor produced in vitro by Kaposi's sarcoma cells induces and sustains in vivo angiogenesis.

Authors:  F Bussolino; M Arese; G Montrucchio; L Barra; L Primo; R Benelli; F Sanavio; M Aglietta; D Ghigo; M R Rola-Pleszczynski
Journal:  J Clin Invest       Date:  1995-08       Impact factor: 14.808

10.  Tumor necrosis factor alpha-induced angiogenesis depends on in situ platelet-activating factor biosynthesis.

Authors:  G Montrucchio; E Lupia; E Battaglia; G Passerini; F Bussolino; G Emanuelli; G Camussi
Journal:  J Exp Med       Date:  1994-07-01       Impact factor: 14.307

View more
  7 in total

1.  Platelet-activating factor increases VE-cadherin tyrosine phosphorylation in mouse endothelial cells and its association with the PtdIns3'-kinase.

Authors:  Hélène Hudry-Clergeon; Dominique Stengel; Ewa Ninio; Isabelle Vilgrain
Journal:  FASEB J       Date:  2005-04       Impact factor: 5.191

2.  PAF produced by human breast cancer cells promotes migration and proliferation of tumor cells and neo-angiogenesis.

Authors:  B Bussolati; L Biancone; P Cassoni; S Russo; M Rola-Pleszczynski; G Montrucchio; G Camussi
Journal:  Am J Pathol       Date:  2000-11       Impact factor: 4.307

3.  Platelet-activating factor regulates cadherin-catenin adhesion system expression and beta-catenin phosphorylation during Kaposi's sarcoma cell motility.

Authors:  Mariarosaria Boccellino; Giovanni Camussi; Alfonso Giovane; Luigi Ferro; Vincenzo Calderaro; Ciro Balestrieri; Lucio Quagliuolo
Journal:  Am J Pathol       Date:  2005-05       Impact factor: 4.307

4.  Human immunodeficiency virus-1 tat induces hyperproliferation and dysregulation of renal glomerular epithelial cells.

Authors:  Pier Giulio Conaldi; Antonella Bottelli; Andreina Baj; Caterina Serra; Lisa Fiore; Giovanni Federico; Benedetta Bussolati; Giovanni Camussi
Journal:  Am J Pathol       Date:  2002-07       Impact factor: 4.307

5.  Proliferative activity of extracellular HIV-1 Tat protein in human epithelial cells: expression profile of pathogenetically relevant genes.

Authors:  Alessia A Bettaccini; Andreina Baj; Roberto S Accolla; Fulvio Basolo; Antonio Q Toniolo
Journal:  BMC Microbiol       Date:  2005-04-27       Impact factor: 3.605

6.  Palliation of bone cancer pain by antagonists of platelet-activating factor receptors.

Authors:  Katsuya Morita; Seiji Shiraishi; Naoyo Motoyama; Tomoya Kitayama; Takashi Kanematsu; Yasuhito Uezono; Toshihiro Dohi
Journal:  PLoS One       Date:  2014-03-17       Impact factor: 3.240

7.  In vivo effect of two first-line ART regimens on inflammatory mediators in male HIV patients.

Authors:  Vasiliki D Papakonstantinou; Maria Chini; Nikos Mangafas; George M Stamatakis; Nickolaos Tsogas; Alexandros B Tsoupras; Katherina Psarra; Elizabeth Fragopoulou; Smaragdi Antonopoulou; Panagiotis Gargalianos; Constantinos A Demopoulos; Marios-C Lazanas
Journal:  Lipids Health Dis       Date:  2014-05-29       Impact factor: 3.876

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.